Kamada
Open
$8.16
Prev. Close
$8.16
High
$8.17
Low
$8.15
Market Snapshot
$466.37M
23.1
0.25
$160.95M
393
Kamada Ltd. is a biopharmaceutical company, which focuses on specialty plasma-derived therapeutic. The firm uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.
emptyResult
Kamada Ltd. is a biopharmaceutical company, which focuses on specialty plasma-derived therapeutic. The firm uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.
Recently from Cashu
Kamada Prepares for Crucial Earnings Announcement Amid Strategic Growth Efforts
Kamada Gears Up for Key Earnings Announcement Amid Strategic Growth Kamada, a biopharmaceutical company specializing in the development of specialty drugs and therapies, is on the brink of announcing…
Kamada Prioritizes Operational Efficiency and Strategic Partnerships During Earnings Season
Kamada's Strategic Focus on Operational Efficiency Amid Earnings Season Kamada, a biopharmaceutical company specializing in the development of innovative therapies, is currently navigating a critical…
Kamada: Innovating in Biopharmaceuticals for Rare Diseases and Patient-Centric Solutions
Kamada's Strategic Position in the Biopharmaceutical Sector Kamada, a biopharmaceutical company specializing in the development and production of therapeutic proteins, continues to solidify its role i…
Please provide the content you would like me to summarize regarding Kamada.
Sure! Please provide the text you would like me to summarize, and I'll be happy to help.